Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Share-based Compensation (2016 - 2025)

INVO Fertility (IVF) has disclosed Share-based Compensation for 15 consecutive years, with $1.1 million as the latest value for Q3 2025.

  • Quarterly Share-based Compensation rose 410.33% to $1.1 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $941017.0 through Sep 2025, up 330.93% year-over-year, with the annual reading at $153.0 for FY2024, 99.95% down from the prior year.
  • Share-based Compensation for Q3 2025 was $1.1 million at INVO Fertility, up from $11875.0 in the prior quarter.
  • The five-year high for Share-based Compensation was $1.2 million in Q4 2022, with the low at -$791647.0 in Q4 2021.
  • Average Share-based Compensation over 5 years is $163742.6, with a median of $79479.0 recorded in 2022.
  • The sharpest move saw Share-based Compensation tumbled 374.11% in 2021, then soared 76698.91% in 2025.
  • Over 5 years, Share-based Compensation stood at -$791647.0 in 2021, then soared by 252.64% to $1.2 million in 2022, then plummeted by 151.05% to -$616855.0 in 2023, then soared by 66.08% to -$209218.0 in 2024, then skyrocketed by 610.33% to $1.1 million in 2025.
  • According to Business Quant data, Share-based Compensation over the past three periods came in at $1.1 million, $11875.0, and $70655.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.